These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4326832)

  • 21. Some kinetic properties of yeast phosphofructokinase desensitized to inhibition by adenosine triphosphate.
    Karadsheh NS; Ramaiah A
    Biochim Biophys Acta; 1972 Sep; 284(1):110-4. PubMed ID: 4262961
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on heart phosphofructokinase. Binding properties of native enzyme and of enzyme desensitized to allosteric control.
    Lorenson MY; Mansour TE
    J Biol Chem; 1969 Dec; 244(23):6420-31. PubMed ID: 4242924
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on heart phosphofructokinase. Nature of the enzyme desensitized to allosteric control by photo-oxidation and by acylation with ethoxyformic anhydride.
    Setlow B; Mansour TE
    J Biol Chem; 1970 Nov; 245(21):5524-33. PubMed ID: 4319561
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions of Fructose 1,6-diphosphate, substrates, and monovalent cations with yeast pyruvate kinase monitored by changes in enzyme fluorescence.
    Kuczenski RT; Suelter CH
    Biochemistry; 1971 Jul; 10(15):2862-6. PubMed ID: 5114528
    [No Abstract]   [Full Text] [Related]  

  • 25. Yeast phosphofructokinase. 3. Comparison of the allosteric properties of PFKs and PFKd(MgF + ).
    Afting EG; Ruppert D
    Arch Biochem Biophys; 1973 Jun; 156(2):720-9. PubMed ID: 4268880
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on heart phosphofructokinase. Desensitization of the enzyme to adenosine triphosphate inhibition.
    Ahlfors CE; Mansour TE
    J Biol Chem; 1969 Mar; 244(5):1247-51. PubMed ID: 4237418
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of metabolites by phosphofructokinase.
    Kemp RG; Krebs EG
    Biochemistry; 1967 Feb; 6(2):423-34. PubMed ID: 4227735
    [No Abstract]   [Full Text] [Related]  

  • 28. A mathematical model for the influence of fructose 6-phosphate, ATP, potassium, ammonium and magnesium on the phosphofructokinase from rat erythrocytes;
    Otto M; Heinrich R; KUHN B; Jacobasch G
    Eur J Biochem; 1974 Nov; 49(1):169-78. PubMed ID: 4282073
    [No Abstract]   [Full Text] [Related]  

  • 29. Two interconvertible forms of yeast phosphofructokinase with different sensitivity to endproduct inhibition.
    Viñuela E; Salas ML; Salas M; Sols A
    Biochem Biophys Res Commun; 1964 Mar; 15(3):243-9. PubMed ID: 4220804
    [No Abstract]   [Full Text] [Related]  

  • 30. The thermostable allosteric enzyme: phosphofructokinase from an extreme thermophile.
    Yoshida M; Oshima T; Imahori K
    Biochem Biophys Res Commun; 1971 Apr; 43(1):36-9. PubMed ID: 4252961
    [No Abstract]   [Full Text] [Related]  

  • 31. [Actions and interactions of substrates and effectors of phosphofructokinase from rabbit skeletal muscle].
    Hofer HW; Pette D
    Hoppe Seylers Z Physiol Chem; 1968 Oct; 349(10):1378-92. PubMed ID: 4235316
    [No Abstract]   [Full Text] [Related]  

  • 32. [Purification and properties of phosphofructokinase from yeast].
    Jauch R; Riepertinger C; Lynen F
    Hoppe Seylers Z Physiol Chem; 1970 Jan; 351(1):74-80. PubMed ID: 4243865
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic control and structure of glycolytic enzymes. VII. Destabilization and inactivation of yeast glyceraldehyde 3-phosphate dehydrogenase by adenosine phosphates and chymotrypsin.
    Yang ST; Deal WC
    Biochemistry; 1969 Jul; 8(7):2814-20. PubMed ID: 4309125
    [No Abstract]   [Full Text] [Related]  

  • 34. [Yeast phosphofructokinase. Kinetic relations between substrate and effector-binding sites].
    Freyer R; Kubel M; Hofmann E
    Eur J Biochem; 1970 Dec; 17(2):378-85. PubMed ID: 5500407
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification and allosteric properties of yeast pyruvate kinase.
    Haeckel R; Hess B; Lauterborn W; Wüster KH
    Hoppe Seylers Z Physiol Chem; 1968 May; 349(5):699-714. PubMed ID: 4386962
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of 2,3-diphosphoglycerate on phosphofructokinase of human erythrocytes?
    Staal GE; Koster JF
    FEBS Lett; 1972 Jun; 23(1):29-30. PubMed ID: 4343616
    [No Abstract]   [Full Text] [Related]  

  • 37. Myocardial adenine nucleotides, hexose phosphates and inorganic phosphate, and the regulation of phosphofructokinase activity during fluoroacetate poisoning in the rat.
    Godoy HM; del Carmen Villarruel M
    Biochem Pharmacol; 1974 Nov; 23(22):3179-89. PubMed ID: 4155303
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the properties of the phosphofructokinases of the fat body and flight muscle of the adult male desert locust.
    Walker PR; Bailey E
    Biochem J; 1969 Feb; 111(3):365-9. PubMed ID: 4304161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic control and structure of glycolytic enzymes. VI. Competitive inhibition of yeast glyceraldehyde 3-phosphate dehydrogenase by cyclic adenosine monophosphate, adenosine triphosphate, and other adenine-containing compounds.
    Yang ST; Deal WC
    Biochemistry; 1969 Jul; 8(7):2806-13. PubMed ID: 4390104
    [No Abstract]   [Full Text] [Related]  

  • 40. [An allosteric enzyme with 2 substrates: phosphofructokinase from rat muscle. IV. Conjugated action of 2 allosteric inhibitors, ATP and citrate].
    Odeide R; Dupuis B; Guilloton M; Savany A; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1969 Dec; 51(7):1199-210. PubMed ID: 4243437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.